Treatment of chlamydial genital infection

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 3, 1997, Pages 311-314

  Ridgway, Geoffrey L ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; GENITAL TRACT INFECTION; SHORT SURVEY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; MALE; PENICILLINS; TETRACYCLINES;

EID: 0030850348     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.3.311     Document Type: Short Survey

References (30)

1. Centers for Disease Control and Prevention. (1993). Recommendations for the prevention and management of Chlamydia trachomatis infections. Morbidity and Mortality Weekly Report 42, RR-12, 1-39.
2. Jones, R. B., Van der Pol, B., Martin, D. H. & Shephard, W. A. (1990). Partial characterisation of Chlamydia trachomatis resistant to multiple antibiotics. Journal of Infectious Diseases 162, 1309-15.
3. Alary, M., Joly, J.-R., Moutquin, J. M., Mondor, M., Boucher, M., Fortier, A. et al. (1994). Randomised comparison of amoxycillin and erythromycin in treatment of genital chlamydial infection in pregnancy. Lancet 344, 1461-5.
4. Oriel, J. D. (1986). Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis. Journal of Antimicrobial Chemotherapy 18, Suppl. D, 129-32.
5. Ridgway, G. L. (1993). Quinolones in sexually transmitted diseases. Drugs 45, Suppl. 3, 134-8.
6. van der Willigen, A. H., van Rijsoord-Vos, T., Wagenvoort, J. H., Stamm, W. E., Suchland, R. J. & Stolz, E. (1992). Antimicrobial susceptibility and serotyping of Chlamydia trachomatis strains isolated before and after treatment with ciprofloxacin and doxycycline. European Journal of Clinical Microbiology and Infectious Diseases 11, 561-3.
7. Blomer, R., Bruch, K. & Klose, U. (1988) Ofloxacin in the treatment of gonococcal and chlamydial urethritis. Clinical Therapeutics 10, 263-5.
8. Hooton, T. M., Batteiger, B. E., Judson, F. N., Spruance, S. L. & Stamm, W. E. (1992). Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 36, 1144-6.
9. Kitche, V. S., Donegan, C., Ward, H., Thomas, B. J., Harris, J. R. & Taylor-Robinson, D. (1990). Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infections. Journal of Antimicrobial Chemotherapy 26 Suppl. D, 99-105.
10. Jolley, A., Andrews, J. M., Brenwald, N. & Wise, R. (1993). The in vitro activity of a new highly active quinolone, DU-6859a. Journal of Antimicrobial Chemotherapy 32, 757-63.
11. Wise, R., Andrews, J. M. & Brenwald, N. (1993). The in vitro activity of OPC-17116, a new 5-methyl substituted quinolone. Journal of Antimicrobial Chemotherapy 31, 497-504.
12. Felmingham, D., Robbins, M., Mathias, I., Bhogal, H., Leakey, A., Ridgway, G. et al. (1997). In vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates. Journal of Antimicrobial Chemotherapy 39, 43-49.
13. Nakata, K., Maeda, H., Fuji, A., Arakawa, S., Umezu, K. & Kamidono, S. (1992). In vitro and in vivo activities of sparfloxacin and other quinolones and tetracyclines against Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 36, 188-90.
14. Tanaka, M., Matsumoto, T., Kumazawa, J. & Nayagama, A. (1992). Sparfloxacin in the treatment of males with urethritis. European Journal of Clinical Microbiology and Infectious Diseases 11, 660.
15. Phillips, I., Dimian, C., Barlow, D., Moi, H., Skolz, E., Weidner, W. et al. (1996). A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 123-34.
16. Martin, D., Jones, R. B. & Johnson, R. B. (1997). A Phase II study of trovafloxacin for the treatment of Chlamydia trachomatis infections. Journal of Antimicrobial Chemotherapy 39, in press.
17. Brunham, R. C. (1984). Therapy for acute pelvic inflammatory disease; a critique of recent treatment trials. American Journal of Obstetrics and Gynecology 148, 235-50.
18. Soper, D. E., Brockwell, N. J. & Dalton, H. P. (1992). Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. American Journal of Obstetrics and Gynecology 167, 653-60.
19. Wendel, G. D., Cox, S. M., Bawdon, R. E., Theriot, S. K., Heard, M. C. & Nobles, B. J. (1991). A randomised trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. American Journal of Obstetrics and Gynecology 164, 1390-6.
20. Faro, S. (1991). Ofloxacin in the treatment of STDs. Summary. American Journal of Obstetrics and Gynecology 164, 1399-400.
21. Centers for Disease Control and Prevention. (1993). 1993 Sexually transmitted diseases treatment guidelines. Morbidity and Mortality Weekly Report 42, RR-14, 1-102.
22. Martens, M. G., Gordon, S. G., Yarborough, D. R., Faro, S., Binder, D., Berkeley, A. et al. (1993). Multicentre randomised trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Southern Medical Journal, 86, 604-10.
23. Nielsen, I. K., Engdahl, E. & Larsen, T. (1993). No effect of single dose ofloxacin on postoperative infection rate after first-trimester abortion. Acta Obstetrica et Gynecologica Scandinavica 72, 556-9.
24. Handsfield, H. H. (1993). Sexually transmitted chlamydial infections, gonorrhoea and syphilis. In New Macrolides, Azalides and Streptogramins (Neu, H. C., Young, L. S. & Zinner, S., Eds), pp. 167-72. Marcel Dekker, New York, NY.
25. Ridgway, G. L. (1995). Chlamydia and other sexually transmitted diseases. In New Macrolides, Azalides and Streptogramins in Clinical Practice (Neu, H. C., Young, L. S. & Zinner, S. & Acar, J. F., Eds), pp. 147-54. Marcel Dekker, New York, NY.
26. Bryskier, A., Agouridas, C. & Chantot, J. F. (1993). Structure and activity. In New Macrolides, Azalides and Streptogramins (Neu, H. C., Young, L. S. & Zinner, S., Eds), pp. 3-11. Marcel Dekker, New York, NY.
27. Ridgway, G. L. (1996). Azithromycin in the management of Chlamydia trachomatis infections. International Journal of STD & AIDS, 7, Suppl. 1, 5-8.
28. Carlin, E. M., & Barton, S. E. (1996). Azithromycin as the first-line treatment of non-gonococcal urethritis (NGU): a study of follow-up rates, contact attendance and patients' treatment preference. International Journal of STD & AIDS 7, 185-9.
29. Thorpe, E. M., Stamm, W. E., Hook, E. W., Gall, S. A., Jones, R. B., Henry, K. et al. (1996). Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practices. Genitourinary Medicine 72, 93-7.
30. Stamm, W. E., Hicks, C. B., Martin, D. H., Leone, P., Hook, E. W., Cooper, R. H. et al. (1995). Azithromycin for empirical treatment of the non-gonococcal urethritis syndrome in men: a randomized double-blind study. Journal of the American Medical Association 274, 545-9.